In the 31st episode of “Travels With Charlie — Vermont Politics in Real Life,” host Charlie Papillo covers Jenna’s House in Johnson, Vermont, whose founders want to provide wholistic addiction treatment and recovery services. Guests are Greg Tatro, founder of Jenna’s Promise, and Daniel Franklin, executive director of North Central Vermont Recovery Center.
Why are Hartford drug dealers targeting Vermont? A reading of police and media reports suggests at least three reasons: Gangs, greed and guns.
The Department of Justice on Wednesday announced a global resolution of its criminal and civil investigations into the opioid manufacturer Purdue Pharma. The resolutions with Purdue are subject to the approval of the bankruptcy court.
Twice as many people have died in car crashes so far this year compared to 2019. Opioid overdoses are up 50%. In both cases state officials say the pandemic is at least partly to blame.
Fewer regulations and related expenses for businesses will improve incomes, decrease housing expenses, encourage investment and instill hope. This will reduce suicides, domestic violence and illicit drug use.
A large drug-running operation involving Rutland residents and New York City-area individuals has been broken up in a sweeping crackdown by local, state and federal authorities, the Vermont Office of the United States Attorney announced Friday.
New Hampshire has announced the cancellation of its contract with the Granite Pathways Youth Treatment Center, following the recent hospitalization of teen residents who overdosed at the Manchester facility.
About a dozen law enforcement and drug treatment professionals met Monday evening at St. Johnsbury Middle School to discuss the state of the drug trade, drug addiction and where drugs are coming from that ultimately end up in Vermont.
A mother and daughter from Morrisville are headed to jail after getting caught selling hard drugs including heroin, fentanyl and oxycodone.
In addressing the opioid crisis, Vermont is nationally recognized for its leadership in treatment and recovery initiatives. The Vermont GOP must build on this important progress. Prevention must be the first and foremost weapon in this battle.
Purdue Pharma, which has earned $35 billion from the sale of OxyContin alone, has offered to pay $10 billion to $12 billion to settle the claims after meeting with at least 10 state attorneys general and plaintiffs’ attorneys in Cleveland last week.